• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖测量指标与代谢综合征通过肥胖成年人循环中的神经调节蛋白4和脂肪酶水平相关联。

Adiposity Measurements and Metabolic Syndrome Are Linked Through Circulating Neuregulin 4 and Adipsin Levels in Obese Adults.

作者信息

Guo Dan, Liu Jianfang, Zhang Peizhen, Yang Xiaoyu, Liu Deying, Lin Jiayang, Wei Xueyun, Xu Bingyan, Huang Chensihan, Zhou Xuan, Teng Fei, Zhu Hong, Zhang Huijie

机构信息

Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Department of Endocrinology and Diabetes, The First Affiliated Hospital, Xiamen University, Xiamen, China.

出版信息

Front Physiol. 2021 May 4;12:667330. doi: 10.3389/fphys.2021.667330. eCollection 2021.

DOI:10.3389/fphys.2021.667330
PMID:34017266
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8129583/
Abstract

BACKGROUND

Adiposity and adipokines are associated with metabolic disorders, but little is known regarding that whether adiposity measurements link metabolic syndrome (MetS) through circulating neuregulin 4 (Nrg4) and adipsin levels.

MATERIALS AND METHODS

A total of 1212 subjects with a waist circumference greater than 90 cm for men or 80 cm for women were enrolled from a Chinese community. Circulating Nrg4 and adipsin levels were measured using commercial kits. Mediation analyses of circulating Nrg4 and adipsin were performed in the study using linear and logistic regression.

RESULTS

Subjects with MetS had higher waist circumference, visceral fat level, and circulating adipsin level, and lower levels of circulating Nrg4 and muscle mass to visceral fat (MVF) ratio (all < 0.05). In multivariable logistic regression analyses, after adjusting for confounding variables, per standard deviation (SD) increase in waist circumference and visceral fat level were significantly associated with increased odds of MetS [OR (95% CI), 1.42 (1.22-1.64); 2.20 (1.62-2.99); respectively]; and per SD reduction in MVF ratio was significantly associated with reduced odds of MetS [OR (95% CI), 0.65 (0.55-0.77)]. In the mediation analyses, both circulating Nrg4 and adipsin levels mediated the association between waist circumference (8.31% and 18.35%, respectively), visceral fat level (7.50% and 9.98%, respectively), and MVF ratio (5.80% and 9.86%, respectively) and MetS after adjustments.

CONCLUSION

These findings indicate that adiposity measurements and MetS are linked through circulating Nrg4 and adipsin levels in obese adults, suggesting that circulating Nrg4 and adipsin levels might be potential predictors for management of MetS.

摘要

背景

肥胖和脂肪因子与代谢紊乱有关,但关于肥胖测量指标是否通过循环神经调节蛋白4(Nrg4)和脂肪酶水平与代谢综合征(MetS)相关,人们知之甚少。

材料与方法

从一个中国社区招募了总共1212名腰围男性大于90厘米或女性大于80厘米的受试者。使用商业试剂盒测量循环Nrg4和脂肪酶水平。在该研究中,采用线性和逻辑回归对循环Nrg4和脂肪酶进行中介分析。

结果

患有代谢综合征的受试者腰围、内脏脂肪水平和循环脂肪酶水平较高,而循环Nrg4水平和肌肉量与内脏脂肪(MVF)比值较低(均P<0.05)。在多变量逻辑回归分析中,调整混杂变量后,腰围和内脏脂肪水平每增加一个标准差(SD),与代谢综合征发生几率增加显著相关[比值比(95%置信区间)分别为1.42(1.22 - 1.64);2.20(1.62 - 2.99)];MVF比值每降低一个标准差,与代谢综合征发生几率降低显著相关[比值比(95%置信区间)为0.65(0.55 - 0.77)]。在中介分析中,调整后循环Nrg4和脂肪酶水平均介导了腰围(分别为8.31%和18.35%)、内脏脂肪水平(分别为7.50%和9.98%)以及MVF比值(分别为5.80%和9.86%)与代谢综合征之间的关联。

结论

这些发现表明,在肥胖成年人中,肥胖测量指标与代谢综合征通过循环Nrg4和脂肪酶水平相关联,提示循环Nrg4和脂肪酶水平可能是代谢综合征管理的潜在预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0463/8129583/ee5942e9547b/fphys-12-667330-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0463/8129583/c31159d78c25/fphys-12-667330-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0463/8129583/e5c9719d9e16/fphys-12-667330-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0463/8129583/ee5942e9547b/fphys-12-667330-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0463/8129583/c31159d78c25/fphys-12-667330-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0463/8129583/e5c9719d9e16/fphys-12-667330-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0463/8129583/ee5942e9547b/fphys-12-667330-g003.jpg

相似文献

1
Adiposity Measurements and Metabolic Syndrome Are Linked Through Circulating Neuregulin 4 and Adipsin Levels in Obese Adults.肥胖测量指标与代谢综合征通过肥胖成年人循环中的神经调节蛋白4和脂肪酶水平相关联。
Front Physiol. 2021 May 4;12:667330. doi: 10.3389/fphys.2021.667330. eCollection 2021.
2
Association of circulating neuregulin 4 with metabolic syndrome in obese adults: a cross-sectional study.肥胖成年人循环神经调节蛋白4与代谢综合征的关联:一项横断面研究。
BMC Med. 2016 Oct 24;14(1):165. doi: 10.1186/s12916-016-0703-6.
3
Association of circulating adipsin with nonalcoholic fatty liver disease in obese adults: a cross-sectional study.肥胖成年人循环脂联素与非酒精性脂肪性肝病的关联:一项横断面研究。
BMC Gastroenterol. 2021 Mar 21;21(1):131. doi: 10.1186/s12876-021-01721-9.
4
Implications of the Serum Concentrations of Neuregulin-4 (Nrg4) in Patients with Coronary Artery Disease: A Case-Control Study.冠心病患者血清神经调节蛋白4(Nrg4)浓度的意义:一项病例对照研究。
J Tehran Heart Cent. 2023 Jul;18(3):170-176. doi: 10.18502/jthc.v18i3.14111.
5
Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.循环神经调节蛋白4水平与多囊卵巢综合征的代谢、动脉粥样硬化及抗苗勒管激素特征之间的关联
J Obstet Gynaecol. 2019 Oct;39(7):975-980. doi: 10.1080/01443615.2019.1581754. Epub 2019 May 7.
6
Metabolic Score for Visceral Fat: A reliable indicator of visceral obesity for predicting risk for hypertension.代谢性内脏脂肪评分:预测高血压风险的可靠内脏肥胖指标。
Nutrition. 2022 Jan;93:111443. doi: 10.1016/j.nut.2021.111443. Epub 2021 Aug 10.
7
Plasma Neuregulin 4 Levels Are Associated with Metabolic Syndrome in Patients Newly Diagnosed with Type 2 Diabetes Mellitus.血浆神经调节蛋白 4 水平与新诊断 2 型糖尿病患者代谢综合征相关。
Dis Markers. 2018 Mar 12;2018:6974191. doi: 10.1155/2018/6974191. eCollection 2018.
8
Circulating neuregulin 4 levels are inversely associated with subclinical cardiovascular disease in obese adults.循环神经调节蛋白 4 水平与肥胖成年人亚临床心血管疾病呈负相关。
Sci Rep. 2016 Nov 7;6:36710. doi: 10.1038/srep36710.
9
Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.伴有和不伴有2型糖尿病的肥胖患者的内脏脂肪测量、代谢及炎症特征:一项横断面分析
Curr Diabetes Rev. 2017;13(1):11-18. doi: 10.2174/1573399812666151015115924.
10
The relation between body fat distribution, plasma concentrations of adipokines and the metabolic syndrome in patients with clinically manifest vascular disease.有临床显性血管病患者的体脂分布、脂肪因子的血浆浓度与代谢综合征之间的关系。
Eur J Prev Cardiol. 2018 Sep;25(14):1548-1557. doi: 10.1177/2047487318790722. Epub 2018 Jul 27.

引用本文的文献

1
Predictive study of machine learning combined with serum Neuregulin 4 levels for hyperthyroidism in type II diabetes mellitus.机器学习结合血清神经调节蛋白4水平对2型糖尿病合并甲状腺功能亢进症的预测研究
Front Oncol. 2025 Jul 16;15:1595553. doi: 10.3389/fonc.2025.1595553. eCollection 2025.
2
Unraveling the complexities of diet induced obesity and glucolipid dysfunction in metabolic syndrome.解析代谢综合征中饮食诱导的肥胖和糖脂功能障碍的复杂性。
Diabetol Metab Syndr. 2025 Jul 22;17(1):292. doi: 10.1186/s13098-025-01837-y.
3
Secreted proteins in treating metabolic dysfunction-associated steatotic liver disease: from bench towards bedside.

本文引用的文献

1
Healthy and non healthy obese patients. The truth lies in the adipose tissue.健康和非健康肥胖患者。真相存在于脂肪组织中。
Eur J Intern Med. 2020 Dec;82:133-134. doi: 10.1016/j.ejim.2020.08.017. Epub 2020 Aug 20.
2
Trends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016.美国代谢综合征流行趋势,2011-2016 年。
JAMA. 2020 Jun 23;323(24):2526-2528. doi: 10.1001/jama.2020.4501.
3
The role of C-reactive protein, adiponectin and leptin in the association between abdominal adiposity and insulin resistance in middle-aged individuals.
治疗代谢功能障碍相关脂肪性肝病的分泌蛋白:从 bench 到 bedside
Protein Cell. 2025 Aug 7;16(8):641-666. doi: 10.1093/procel/pwaf027.
4
Low circulating levels of neuregulin 4 as a potential biomarker associated with the severity and prognosis of obesity-related metabolic diseases: a systematic review.神经调节蛋白 4 水平降低作为与肥胖相关代谢性疾病严重程度和预后相关的潜在生物标志物:系统评价。
Adipocyte. 2024 Dec;13(1):2390833. doi: 10.1080/21623945.2024.2390833. Epub 2024 Aug 20.
5
Adipokine modulation in obesity: Evaluating the integrative impact of chlorella vulgaris supplementation and interval resistance training in obese males.肥胖中的脂肪因子调节:评估补充小球藻和间歇性阻力训练对肥胖男性的综合影响。
J Funct Foods. 2024 Aug;119. doi: 10.1016/j.jff.2024.106315. Epub 2024 Jun 25.
6
A comparison of brown fat tissue related hormone levels in metabolically healthy and unhealthy individuals with obesity.比较肥胖的代谢健康和不健康个体的棕色脂肪组织相关激素水平。
Endocrine. 2024 Dec;86(3):1025-1034. doi: 10.1007/s12020-024-03960-8. Epub 2024 Jul 15.
7
Lipid metabolic reprogramming mediated by circulating Nrg4 alleviates metabolic dysfunction-associated steatotic liver disease during the early recovery phase after sleeve gastrectomy.循环 NRG4 通过脂质代谢重编程减轻袖状胃切除术后早期恢复阶段与代谢功能障碍相关的脂肪性肝病。
BMC Med. 2024 Apr 17;22(1):164. doi: 10.1186/s12916-024-03377-0.
8
Biomarkers in Systemic Lupus Erythematosus along with Metabolic Syndrome.系统性红斑狼疮与代谢综合征中的生物标志物
J Clin Med. 2024 Mar 29;13(7):1988. doi: 10.3390/jcm13071988.
9
Gut Microbiome and Metabolic and Immune Indices in Males with or without Evidence of Metabolic Dysregulation.有或无代谢失调证据的男性的肠道微生物群与代谢和免疫指标
J Obes Metab Syndr. 2024 Mar 30;33(1):64-75. doi: 10.7570/jomes23022. Epub 2024 Mar 21.
10
Metabolic Syndrome: A Narrative Review from the Oxidative Stress to the Management of Related Diseases.代谢综合征:从氧化应激到相关疾病管理的叙述性综述
Antioxidants (Basel). 2023 Dec 8;12(12):2091. doi: 10.3390/antiox12122091.
C 反应蛋白、脂联素和瘦素在中年人群中腹部肥胖与胰岛素抵抗的相关性中的作用。
Nutr Metab Cardiovasc Dis. 2020 Jul 24;30(8):1306-1314. doi: 10.1016/j.numecd.2020.04.021. Epub 2020 May 5.
4
A systematic review of the association of neuregulin 4, a brown fat-enriched secreted factor, with obesity and related metabolic disturbances.神经调节蛋白 4 与肥胖及相关代谢紊乱关系的系统评价:一种富含棕色脂肪的分泌因子
Obes Rev. 2020 Feb;21(2):e12952. doi: 10.1111/obr.12952. Epub 2019 Nov 28.
5
Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status: A Nationwide Population-Based Study of Approximately 10 Million Persons.代谢综合征状态改变与心血管事件风险变化:一项约 1000 万人的全国性基于人群研究。
Ann Intern Med. 2019 Dec 17;171(12):875-884. doi: 10.7326/M19-0563. Epub 2019 Nov 26.
6
Identification of Adipsin as a Novel Prognostic Biomarker in Patients With Coronary Artery Disease.鉴定内脂素为冠心病患者的一种新的预后生物标志物。
J Am Heart Assoc. 2019 Dec 3;8(23):e013716. doi: 10.1161/JAHA.119.013716. Epub 2019 Nov 22.
7
Adipsin preserves beta cells in diabetic mice and associates with protection from type 2 diabetes in humans. adiposin 可保护糖尿病小鼠的胰岛β细胞,并与人类 2 型糖尿病的保护作用相关联。
Nat Med. 2019 Nov;25(11):1739-1747. doi: 10.1038/s41591-019-0610-4. Epub 2019 Nov 7.
8
Role of Complement and Complement-Related Adipokines in Regulation of Energy Metabolism and Fat Storage.补体及补体相关脂肪因子在能量代谢和脂肪存储调节中的作用。
Compr Physiol. 2019 Sep 19;9(4):1411-1429. doi: 10.1002/cphy.c170037.
9
Association between plasma adipsin level and mild cognitive impairment in Chinese patients with type 2 diabetes: a cross-sectional study.血浆脂联素水平与中国 2 型糖尿病患者轻度认知功能障碍的关系:一项横断面研究。
BMC Endocr Disord. 2019 Oct 24;19(1):108. doi: 10.1186/s12902-019-0431-y.
10
Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome.代谢综合征发病机制中的脂肪组织改变和脂肪细胞功能障碍。
J Clin Invest. 2019 Oct 1;129(10):3990-4000. doi: 10.1172/JCI129187.